Effect of choice of reference equation on analysis of pulmonary function in cystic fibrosis patients*
- 22 March 2001
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 31 (3) , 227-237
- https://doi.org/10.1002/ppul.1033
Abstract
Pulmonary function is an important measure of disease severity and prognosis in cystic fibrosis (CF). It is generally expressed as a percentage of a predicted value, calculated using regression equations derived from a reference population. A number of reference equations are in widespread use. The purposes of this study were to determine: 1) the extent to which, for a given absolute FEV1 value, percent of predicted (PPFEV1) values vary when derived by different reference equations; and 2) whether these differences affect conclusions of longitudinal and cross‐sectional analyses. Subjects were all Caucasians 6–18 years old in the 1990 Cystic Fibrosis Foundation Registry. We found clinically important discrepancies in PPFEV1 when calculated by the methods of Dockery et al. [Am Rev Respir Dis 1 ;128:405–412] and Wang et al. [Pediatr Pulmonol 2 ;15:75–78] as compared to Knudson et al. [Am Rev Respir Dis 3 ;127:725–734] or Polgar and Promadhat [Pulmonary Function Testing in Children 4 ; Philadelphia: W.B. Saunders]. In longitudinal analyses, the choice of reference equation resulted in varying apparent rates of decline in FEV1. For example, among subjects ages 12–14 years in 1990, the decline in PPFEV1 from 1990–1995 varied between 2–11%, depending on the choice of reference equation. In cross‐sectional analyses, the choice of reference equation affected the distribution of subjects classified as having mild, moderate, or severe lung disease. CF physicians should be aware of the impact of choice of reference equation in both clinical care and research. Pediatr Pulmonol. 2001; 31:227–237.Keywords
This publication has 26 references indexed in Scilit:
- Intermittent Administration of Inhaled Tobramycin in Patients with Cystic FibrosisNew England Journal of Medicine, 1999
- Gender differences in cystic fibrosis: Pseudomonas aeruginosa infectionJournal of Clinical Epidemiology, 1995
- A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosisThe Journal of Pediatrics, 1995
- Effect of High-Dose Ibuprofen in Patients with Cystic FibrosisNew England Journal of Medicine, 1995
- Outcome measures for clinical trials in cystic fibrosis Summary of a Cystic Fibrosis Foundation Consensus ConferenceThe Journal of Pediatrics, 1994
- Lung function in white children aged 4 to 19 years: I--Spirometry.Thorax, 1993
- Pulmonary function between 6 and 18 years of agePediatric Pulmonology, 1993
- The changing epidemiology of cystic fibrosisThe Journal of Pediatrics, 1993
- Height and age adjustment for cross sectional studies of lung function in children aged 6-11 years.Thorax, 1992
- Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patientsJournal of Clinical Epidemiology, 1990